
Rare Laryngeal Leiomyosarcoma Successfully Treated with Surgery and Adjuvant Chemotherapy
May 13, 2026 - 00:04:26
Radio and PodcastLive Radio & Podcasts
The rapid development and global deployment of mRNA vaccines for COVID-19 represented a landmark achievement in public health. However, the novel mechanism of these “genetic vaccines”—technically pro-drug gene therapies...
mRNA COVID-19 Vaccination and Cancer Risk: A Case-Based Review is an episode from Oncotarget by Oncotarget Podcast. The rapid development and global deployment of mRNA vaccines for COVID-19 represented a landmark achievement in public healt...
This episode belongs to Oncotarget.
Use the player on this page to stream the episode online.
Published Feb 27, 2026, 00:08:38 long, audio available.
The rapid development and global deployment of mRNA vaccines for COVID-19 represented a landmark achievement in public health. However, the novel mechanism of these “genetic vaccines”—technically pro-drug gene therapies encased in lipid nanoparticles—has prompted ongoing scientific inquiry into their potential long-term effects. A comprehensive case report and review, titled “Exploring the potential link between mRNA COVID-19 vaccinations and cancer: A case report with a review of haematopoietic malignancies with insights into pathogenic mechanisms” published in Oncotarget by an international team of researchers investigates a consequential scientific question: whether there could be a link between mRNA COVID-19 vaccines and the development of haematopoietic cancers. Led by first author Patrizia Gentilini, along with corresponding author Panagis Polykretis of the “Allineare Sanità e Salute” Foundation and Independent Medical Scientific Commission (CMSi), Milano, the paper presents a detailed case study alongside a systematic review of existing literature. It does not claim to have proven a causal link, but instead argues that the convergence of clinical observations and proposed biological mechanisms warrants deeper, more urgent investigation. Full blog - Paper DOI - Correspondence to - Panagis Polykretis - panagis.polykretis@gmail.com Abstract video - Sign up for free Altmetric alerts about this article -
You can listen to mRNA COVID-19 Vaccination and Cancer Risk: A Case-Based Review online on Radio and Podcast. Open the player on this page to stream the available audio.
mRNA COVID-19 Vaccination and Cancer Risk: A Case-Based Review is an episode from Oncotarget by Oncotarget Podcast.
This episode is 00:08:38 long.
This episode was published on Feb 27, 2026.
Yes. Use the heart button on the episode page to add it to your favorite episodes list.
Yes. This page shows related episodes from Oncotarget when more episodes are available from the podcast feed.
You can listen to mRNA COVID-19 Vaccination and Cancer Risk: A Case-Based Review on this page when the episode audio is available from the podcast feed.
mRNA COVID-19 Vaccination and Cancer Risk: A Case-Based Review is from Oncotarget by Oncotarget Podcast.
Published Feb 27, 2026 and 00:08:38 long